Phase I clinical trial of MAF containing preparation of RPMI-1788 B-cell human lymphoblastoid lymphokine in advanced cancer patients.

Reynolds, R D

Phase I clinical trial of MAF containing preparation of RPMI-1788 B-cell human lymphoblastoid lymphokine in advanced cancer patients. [electronic resource] - Lymphokine research 1986 - S165-70 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0277-6766


B-Lymphocytes--immunology
Drug Evaluation
Female
Fever--chemically induced
Humans
Immunotherapy
Infusions, Intravenous
Injections, Subcutaneous
Lymphokines--administration & dosage
Macrophage-Activating Factors
Male
Neoplasms--immunology